tradingkey.logo

Bionano Genomics Inc

BNGO
1.150USD
0.0000.00%
Horário de mercado ETCotações atrasadas em 15 min
11.19MValor de mercado
PerdaP/L TTM

Bionano Genomics Inc

1.150
0.0000.00%

Mais detalhes de Bionano Genomics Inc Empresa

Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).

Informações de Bionano Genomics Inc

Código da empresaBNGO
Nome da EmpresaBionano Genomics Inc
Data de listagemAug 01, 2018
CEOHolmlin (R. Erik)
Número de funcionários98
Tipo de títulosOrdinary Share
Fim do ano fiscalAug 01
Endereço9540 Towne Centre Drive
CidadeSAN DIEGO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal92121
Telefone18588887600
Sitehttps://bionano.com/
Código da empresaBNGO
Data de listagemAug 01, 2018
CEOHolmlin (R. Erik)

Executivos da empresa Bionano Genomics Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
382.00
-59.00%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
264.00
-7.00%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-1.00%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-91.00%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--
Dr. Albert A. Luderer, Ph.D.
Dr. Albert A. Luderer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Kristiina Vuori, M.D., Ph.D.
Dr. Kristiina Vuori, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Yvonne Linney, Ph.D.
Dr. Yvonne Linney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Alka Chaubey, Ph.D.
Dr. Alka Chaubey, Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
382.00
-59.00%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
264.00
-7.00%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-1.00%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-91.00%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
Por EmpresaUSD
Nome
Receita
Proporção
Consumables
3.77M
51.21%
Instruments
1.62M
21.98%
Software
1.54M
20.93%
Services and other
433.00K
5.88%
Por RegiãoUSD
Nome
Receita
Proporção
EMEIA
3.63M
49.30%
Americas
2.85M
38.62%
Asia Pacific
890.00K
12.08%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Consumables
3.77M
51.21%
Instruments
1.62M
21.98%
Software
1.54M
20.93%
Services and other
433.00K
5.88%

Distribuição de ações

Atualizado em: sáb, 7 de fev
Atualizado em: sáb, 7 de fev
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Lincoln Alternative Strategies LLC
5.16%
Heights Capital Management, Inc.
4.67%
GSA Capital Partners LLP
3.32%
Abbe (Richard)
3.17%
Iroquois Capital Management, LLC
1.91%
Outro
81.77%
Investidores
Investidores
Proporção
Lincoln Alternative Strategies LLC
5.16%
Heights Capital Management, Inc.
4.67%
GSA Capital Partners LLP
3.32%
Abbe (Richard)
3.17%
Iroquois Capital Management, LLC
1.91%
Outro
81.77%
Tipos de investidores
Investidores
Proporção
Investment Advisor
6.35%
Hedge Fund
5.39%
Corporation
5.16%
Individual Investor
3.19%
Investment Advisor/Hedge Fund
0.37%
Research Firm
0.10%
Outro
79.44%

Participação acionária institucional

Atualizado em: seg, 8 de dez
Atualizado em: seg, 8 de dez
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
124
1.24M
12.21%
+934.19K
2025Q3
133
914.11K
2.58%
+813.59K
2025Q2
185
100.52K
13.17%
-3.70K
2025Q1
250
104.22K
14.32%
-326.48K
2024Q4
274
101.50K
13.43%
+9.88K
2024Q3
289
91.66K
15.30%
-74.07K
2024Q2
302
110.36K
23.52%
-110.43K
2024Q1
309
82.51K
16.21%
-65.29K
2023Q4
315
103.94K
16.84%
+13.56K
2023Q3
336
90.39K
20.40%
+284.00
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Lincoln Alternative Strategies LLC
525.00K
5.16%
+525.00K
--
Sep 17, 2025
Heights Capital Management, Inc.
475.00K
4.67%
+475.00K
--
Sep 16, 2025
Abbe (Richard)
322.53K
3.17%
+322.53K
--
Sep 30, 2025
Iroquois Capital Management, LLC
194.66K
1.91%
+194.66K
--
Sep 30, 2025
The Vanguard Group, Inc.
50.46K
0.5%
+50.46K
--
Sep 30, 2025
Geode Capital Management, L.L.C.
26.84K
0.26%
+7.97K
+42.22%
Sep 30, 2025
Carret Asset Management, LLC
25.00K
0.25%
+25.00K
--
Sep 30, 2025
HRT Financial LP
20.33K
0.2%
+20.33K
--
Sep 30, 2025
Two Sigma Investments, LP
15.58K
0.15%
+15.58K
--
Sep 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
Invesco RAFI US 1500 Small-Mid ETF
0%
Avantis US Small Cap Equity ETF
0%
Invesco RAFI US 1500 Small-Mid ETF
Proporção0%
Avantis US Small Cap Equity ETF
Proporção0%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Data
Data ex-dividendo
Tipo
Proporção
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
KeyAI